Difficulties in interpreting HbA1c results

Polskie Archiwum Medycyny Wewnetrznej

Volumn 120, Issue 4, 2010, Pages 148-154

  Homa, Katarzyna ^a   Majkowska, Liliana ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Diabetes; Glycated hemoglobin; High pressure liquid chromatography

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; HEMOGLOBIN A1C; HEMOGLOBIN DERIVATIVE; HEMOGLOBIN VARIANT; LOOP DIURETIC AGENT; RIBAVIRIN; SALICYLIC ACID DERIVATIVE;

AFFINITY CHROMATOGRAPHY; ALCOHOL ABUSE; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG MECHANISM; ELECTROPHORESIS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBINOPATHY; HEPATITIS C; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOCHEMISTRY; MEASUREMENT; PRACTICE GUIDELINE; REVIEW; SYMPTOM;

EID: 77952812100     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.913     Document Type: Review

References (57)

1. Niederau CM, Reinauer H. Glycohemoglobins. In: Thomas L, ed. Clinical laboratory diagnostics: use and assessment of clinical laboratory results. Frankfurt am Main, Germany: TH-Books Verlagsgeselschaft mbH; 1998: 142-148.
2. Nathan DM, Kuenen J, Borg R, et al. A1c-Derived Average Glucose (ADAG) Study Group: translating the A1C assay into estimated average glucose values. Diabetes Care. 2008; 31: 1473-1478.
3. Tahara Y, Shima K. The response of GHb to stepwise plasma glucose change over time in diabetic patients. Diabetes Care. 1993; 16: 1313-1314. (Pubitemid 23259881)
4. Selvin E, Crainiceanu CM, Brancati FL, et al. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med. 2007; 167: 1545-1551. (Pubitemid 47124186)
5. 1c determination. Diabetologia. 2004; 47: 1143-1148.
6. 1c in human blood. Clin Chem Lab Med. 2002; 40: 78-89.
7. Sacks BD; ADA/EASD/IDF Working Group of the HbA1c Assay. Global harmonization of hemoglobin A1c. Clin Chem. 2005; 51: 681-683.
8. Mosca A, Gooddall I, Hoshino T, et al. Global standarization of glycated hemoglobin meassurement: the position of the IFCC Working Group. Clin Chem Lab Med. 2007; 45: 1077-1080. (Pubitemid 47424866)
9. Day C, Bailey CJ. HbA1c - changing units. The British Journal of Diabetes & Vascular Disease. 2009; 9: 134-136.
10. Nordin G, Dybkaer R. Recommendation for term and measurement unit for "HbA1c". Clin Chem Lab Med. 2007; 45: 1081-1082.
11. Kilpatrick ES. Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus. J Clin Pathol. 2008; 61: 977-982.
12. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993; 329: 977-986.
13. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352: 837-853.
14. Waden J, Forsblom C, Thorn LM, et al. A1c variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes. Diabetes. 2009; 58: 2649-2655.
15. Kilpatrick ES, Rigby AS, Atkin SL. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care. 2006; 29: 1486-1490. (Pubitemid 44127568)
16. Kilpatrick ES, Rigby AS, Atkin SL. A1c variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial. Diabetes Care. 2008; 31: 2198-2202.
17. Sieradzki J, Grzeszczak W, Kasperska-Czyzyk T, et al. [The DINAMIC 2 study: aims, assumptions and methods (I)]. Diabetologia Praktyczna. 2003; 4: 97-102. Polish.
18. Sieradzki J, Kasperska-Czyzyk T, Grzeszczak W, et al. [The DINAMIC 2 results in Poland (H)]. Diabetologia Praktyczna. 2003; 4: 103-111. Polish.
19. Grzeszczak W, Sieradzki J, Kasperska-Czyzyk T, et al. [DINAMIC 2 study: results of comparison among various regions in Poland (III)]. Diabetologia Praktyczna. 2003; 4: 111-124. Polish.
20. Sieradzki J, Grzeszczak W, Kamafel W, et al. [The PolDiab Study. Part I. Analysis of diabetes treatment in Poland]. Diabetologia Praktyczna. 2006; 7: 8-15. Polish.
21. Sieradzki J, Koblik T, Nazar M. [Progress in treatment for type 2 diabetes mellitus based on HbA1c screening in 2002 and 2005). Diabetologia Praktyczna. 2008; 9: 132-139. Polish.
22. Sieradzki J, Nazar M. [Intensification of insulin therapy in Poland. Basic parameters of metabolic control and treatment satisfaction - results of a large trial of patients with type 2 diabetes - Polish]. Diabetologia Praktyczna. 2004; 5: 173-182. Polish.
23. Andel M, Grzeszczak W, Michalek J, et al. [A multinational, multi-centre, observational, cross-sectional survey assessing diabetes secondary care in Central and Eastern Europe (DEPAC Survey)]. Diabet Med. 2008; 25: 1195-1203.
24. Bala MM, Płaczkiewicz-Jankowska E, Topór-Ma̧dry R, et al. Characteristics of patients with type 2 diabetes of short duration in Poland. Rationale, design and preliminary results of the ARETAEUS1 study. Pol Arch Med Wewn. 2009; 119: 533-540.
25. Clinical Practice Recommendations of American Diabetes Association. Diabetes Care. 2010; 33 (Suppl 1): 1S-100S.
26. International Expert Committee. International Expert Committee report on the role of the HbA1c assay in the diagnosis of diabetes. Diabetes Care. 2009; 32: 1327-1344.
27. 2009 Standards of Medical Care in Diabetes; recommendations of Polish Diabetes Association. Diabetologia Praktyczna. 2009; 10 Suppl A.
28. Huisman TH, Marts EA, Dozy A. Chromatography of hemoglobin type on carooxymethylcellulose. J Lab Clin Med. 1958; 52: 312-327.
29. Bookchin RM, Gallop PM. Structure of hemoglobin A1c: nature of N-terminal beta chain blocking group. Biochem Biophys Res Commun. 1968; 32: 86-93.
30. Rahbar S, Blumenfeld O, Ranney HM. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun. 1969; 36: 838-843.
31. Bunn HF, Haney DN, Gabbay KH, Gallop PM. Further identification of the nature and linkage of the carbohydrate in hemoglobin A1c. Biochem Biophys Res Commun. 1975; 67: 103-109.
32. Koenig RJ, Peterson CM, Jones RL, et al. Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med. 1976; 295: 417-420.
33. Little R. Glycated hemoglobin standardization - National Glycohemoglobin Standardization Program (NGSP) perspective. Clin Chem Lab Med. 2003; 41: 1191-1198. (Pubitemid 37265698)
34. Chandalia HB, Krishnaswamy PR. Glycated hemoglobin. Curr Sci. 2002; 83: 1522-1532.
35. Schnedl WJ, Krause R, Halwachs-Baumann G, et al. Evaluation of HbA1c determination methods in patients with hemoglobinopathies. Diabetes Care. 2000; 23: 339-344. (Pubitemid 30131741)
36. Paisey R, Banks R, Horton R, et al. Glycosylated haemoglobin in uraemia. Diabet Med. 1986; 3: 445-448.
37. Debard A, Charmion S, Ben Ameur S, et al. Inappropriate low glycated haemoglobin and haemolysis. Rev Med Interne. 2009; 30: 525-527.
38. Adams AS, Trinacty CM, Zhang F, et al. Medication adherence and racial differences in HbA1c control. Diabetes Care. 2008; 31: 916-921.
39. Schnedl WJ, Reisinger EC, Pieber TR, et al. Hemoglobin Sherwood Forest detected by high performance liquid chromatography for hemoglobin A1c. Am J Clin Pathol. 1995; 104: 444-446.
40. Yagame M, Jinde K, Suzuki D, et al. A diabetic case with hemoglobin J-Meemt and low HbA1c levels. Intern Med. 1997; 36: 351-356. (Pubitemid 127513010)
41. Barakat O, Krishan ST, Dhatariya K. Falsely low HbA1c value due to a rare variant of hemoglobin J-Baltimore. Prim Care Diabetes. 2008; 2: 155-157.
42. O'Brien DA, Flynn CM, Chuk P, et al. Haemoglobin Etobicoke, an incidental finding in an Irish Diabetic. Clin Lab Haematol. 2003; 25: 259-262. (Pubitemid 36963189)
43. Little RR, Rohlfing CL, Hanson S, et al. Effects of hemoglobin (Hb) E and HbD trait on measurements of glycated Hb (HbA1c) by 23 methods. Clin Chem. 2008; 54: 1277-1282.
44. Mongia SK, Little RR, Rohlfing CL, et al. Effects of hemoglobin C and S traits on the results of 14 commercial glycated hemoglobin assays. Am J Clin Pathol. 2008; 130: 136-140.
45. Schnedl WJ, Lahousen T, Lang T, et al. Determination of glycated hemoglobin in clinically silent hemoglobin variants. Diabetes Metab Res Rev. 2004; 20: 460-465. (Pubitemid 40028646)
46. Paisey RB, Read R, Palmer R, et al. Persistent fetal haemoglobin and falsely high glycosylated haemoglobin levels. Br Med J (Clin Res Ed). 1984; 289: 279-280. (Pubitemid 14009086)
47. Rohlfing CL, Connoly SM, England JD, et al. The effect of elevated fetal haemoglobin on haemoglobin A1c results: five common haemoglobin A1c methods compared with the IFCC reference method. Am J Clin Pathol. 2008; 129: 811-814.
48. Weykamp CW, Pendens TJ, Muskiet FA, et al. Influence of hemoglobin variants and derivatives on glycohemoglobin determination, as investigated by 102 laboratories using 16 methods. Clin Chem. 1993; 39: 1717-1723.
49. Chachou A, Randoux C, Millart H, et al. Influence of in vivo hemoglobin carbamylation in HbA1c measurements by various methods. Clin Chem Lab Med. 2000; 38: 321-326. (Pubitemid 30444959)
50. Weykamp CW, Penders TJ, Siebelder CWM, et al. Interference of carbamylated and acetylated hemoglobins in assays of gtycohemoglobin by HPLC, electrophoresis, affinity chromatography, and enzyme immunoassay. Clin Chem. 1993; 39: 138-142.
51. Cerielo A, Giugliano D, Quatraro A, et al. Vitamin E reduction of protein glycosylate in diabetes. New prospect for prevention of diabetic complications? Diabetes Care. 1991; 14: 68-72.
52. Davie SJ, Gould BJ, Yudkin JS. Effect of vitamin C on glycosylation of proteins. Diabetes. 1992; 41: 167-173.
53. Weykamp CW, Penders TJ, Baadenhuijen H, et al. Vitamin C and gtycohemoglobin. Clin Chem. 1995; 41: 713-716.
54. Robertson M. Artificially low HbA1c associated with treatment with ribavirin. BMJ. 2008; 336: 505. (Pubitemid 351347419)
55. Passare G, Fastbom J, Töning O, Viitanen M. Drug use and increased HbA1c levels in non-diabetic very elderly persons: the Kungsholmen project. Eur J Clin Pharmacol. 2004; 60: 121-126. (Pubitemid 38626442)
56. Halwachs-Baumann G, Katzensteiner S, Schnedl W, et al. Comparative evaluation of three assay systems for the automated determination of hemoglobin A1c. Clin Chem. 1997; 43: 511-517. (Pubitemid 27106488)
57. Auxner-Parham S. Testing to keep tight glycemic control. Is there role for intermediate-term control. Clin Lab News. 2004; 30:1-4.